Gerresheimer

Germany

Gerresheimer

Germany
SEARCH FILTERS
Time filter
Source Type

— In this report, the global Perfume Packaging market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Perfume Packaging in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India For more information or any query mail at sales@wiseguyreports.com Global Perfume Packaging market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Rexam Silgan Holding Heinz HCP Gerresheimer Albea Group Amcor SABIC IP Dejin Plastic Packaging RPCGroup Yifang Packaging Shenda Cosmetic Pack Jinuo Glass Sanxing On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Glass Plastic Other On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Perfume Packaging for each application, including Main Container Auxiliary Material If you have any special requirements, please let us know and we will offer you the report as you want. Global Perfume Packaging Market Research Report 2017 1 Perfume Packaging Market Overview 1.1 Product Overview and Scope of Perfume Packaging 1.2 Perfume Packaging Segment by Type (Product Category) 1.2.1 Global Perfume Packaging Production and CAGR (%) Comparison by Type (Product Category) (2012-2022) 1.2.2 Global Perfume Packaging Production Market Share by Type (Product Category) in 2016 1.2.3 Glass 1.2.4 Plastic 1.2.5 Other 1.3 Global Perfume Packaging Segment by Application 1.3.1 Perfume Packaging Consumption (Sales) Comparison by Application (2012-2022) 1.3.2 Main Container 1.3.3 Auxiliary Material 1.4 Global Perfume Packaging Market by Region (2012-2022) 1.4.1 Global Perfume Packaging Market Size (Value) and CAGR (%) Comparison by Region (2012-2022) 1.4.2 North America Status and Prospect (2012-2022) 1.4.3 Europe Status and Prospect (2012-2022) 1.4.4 China Status and Prospect (2012-2022) 1.4.5 Japan Status and Prospect (2012-2022) 1.4.6 Southeast Asia Status and Prospect (2012-2022) 1.4.7 India Status and Prospect (2012-2022) 1.5 Global Market Size (Value) of Perfume Packaging (2012-2022) 1.5.1 Global Perfume Packaging Revenue Status and Outlook (2012-2022) 1.5.2 Global Perfume Packaging Capacity, Production Status and Outlook (2012-2022) 2 Global Perfume Packaging Market Competition by Manufacturers 2.1 Global Perfume Packaging Capacity, Production and Share by Manufacturers (2012-2017) 2.1.1 Global Perfume Packaging Capacity and Share by Manufacturers (2012-2017) 2.1.2 Global Perfume Packaging Production and Share by Manufacturers (2012-2017) 2.2 Global Perfume Packaging Revenue and Share by Manufacturers (2012-2017) 2.3 Global Perfume Packaging Average Price by Manufacturers (2012-2017) 2.4 Manufacturers Perfume Packaging Manufacturing Base Distribution, Sales Area and Product Type 2.5 Perfume Packaging Market Competitive Situation and Trends 2.5.1 Perfume Packaging Market Concentration Rate 2.5.2 Perfume Packaging Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 7 Global Perfume Packaging Manufacturers Profiles/Analysis 7.1 Rexam 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2 Perfume Packaging Product Category, Application and Specification 7.1.2.1 Product A 7.1.2.2 Product B 7.1.3 Rexam Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.1.4 Main Business/Business Overview 7.2 Silgan Holding 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.2.2 Perfume Packaging Product Category, Application and Specification 7.2.2.1 Product A 7.2.2.2 Product B 7.2.3 Silgan Holding Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.2.4 Main Business/Business Overview 7.3 Heinz 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.3.2 Perfume Packaging Product Category, Application and Specification 7.3.2.1 Product A 7.3.2.2 Product B 7.3.3 Heinz Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.3.4 Main Business/Business Overview 7.4 HCP 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.4.2 Perfume Packaging Product Category, Application and Specification 7.4.2.1 Product A 7.4.2.2 Product B 7.4.3 HCP Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.4.4 Main Business/Business Overview 7.5 Gerresheimer 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.5.2 Perfume Packaging Product Category, Application and Specification 7.5.2.1 Product A 7.5.2.2 Product B 7.5.3 Gerresheimer Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.5.4 Main Business/Business Overview 7.6 Albea Group 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.6.2 Perfume Packaging Product Category, Application and Specification 7.6.2.1 Product A 7.6.2.2 Product B 7.6.3 Albea Group Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.6.4 Main Business/Business Overview 7.7 Amcor 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.7.2 Perfume Packaging Product Category, Application and Specification 7.7.2.1 Product A 7.7.2.2 Product B 7.7.3 Amcor Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.7.4 Main Business/Business Overview 7.8 SABIC IP 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.8.2 Perfume Packaging Product Category, Application and Specification 7.8.2.1 Product A 7.8.2.2 Product B 7.8.3 SABIC IP Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.8.4 Main Business/Business Overview 7.9 Dejin Plastic Packaging 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.9.2 Perfume Packaging Product Category, Application and Specification 7.9.2.1 Product A 7.9.2.2 Product B 7.9.3 Dejin Plastic Packaging Perfume Packaging Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.9.4 Main Business/Business Overview For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


News Article | May 4, 2017
Site: www.prnewswire.com

Factors such as increasing demand for different-sized packs and growing focus on packaging as a significant tool for brand differentiation are favouring the growth of the PET packaging market. Moreover, growth in sectors such as food, beverage, personal care, and pharmaceutical, and rise in demand of sustainable & recyclable packaging is fueling the market. The emerging economies of Asia Pacific and Latin America hold a great potential for the PET packaging market. Volatility in raw material prices is hampering the PET packaging market. Bottles & jars are highly chosen due to recyclability, ease and flexibility. PET packaging is ideal in the food industry because it preserves the freshness of food items and extends the shelf life. Asia-Pacific region is expected to grow at a faster pace owing to less labor costs, tremendous industrialization, a vast scope for FDI, and emerging economic conditions. Some of the key players in the market include Smurfit Kappa Group PLC, Rexam PLC, Resilux NV, Klöckner Pentaplast GmbH & Co. Kg, Huhtamaki Group, GTX Hanex Plastic Sp.Z O.O., Graham Packaging Company, Gerresheimer AG, E. I. Du Pont De Nemours and Company (Dupont), Dunmore, CCL Industries, Inc., Berry Plastics Group Inc. and Amcor Limited. Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pet-packaging---global-market-outlook-2016-2022-300451886.html


CORNING, N.Y. and DUSSELDORF, GERMANY; JULY 24, 2017 - Corning Incorporated (NYSE: GLW) and Gerresheimer AG announce that they are accelerating the supply of Corning Valor(TM) Glass to the pharmaceutical industry. Valor Glass is a breakthrough glass container engineered for the storage and delivery of 21st century injectable drugs. Valor Glass is an unprecedented improvement in glass container quality. Valor Glass's superior strength, chemical durability and damage resistance result in better protection for drug products. Valor Glass also enables increased throughput and higher levels of quality assurance for pharmaceutical companies, and higher-quality medicines for patients. Corning and Gerresheimer have been working together since 2015 to accelerate Corning innovations for the pharmaceutical glass packaging market. "We are thrilled to be working with Corning on innovations to enhance quality across the industry. Valor Glass is a remarkable Type I glass with outstanding performance on every attribute," said Uwe Röhrhoff, chief executive officer of Gerresheimer. "Gerresheimer is a long-standing leader in the industry. They've been a terrific collaboration partner, and we're excited to be working with them to bring Valor Glass to the pharmaceutical industry," said Ron Verkleeren, vice president and general manager, Corning Pharmaceutical Technologies. Forward-Looking and Cautionary Statements This press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning's financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events. Digital Media Disclosure In accordance with guidance provided by the SEC regarding the use of company websites and social media channels to disclose material information, Corning Incorporated ("Corning") wishes to notify investors, media, and other interested parties that it intends to use its website (http://www.corning.com/worldwide/en/about-us/news-events.html) to publish important information about the company, including information that may be deemed material to investors. The list of websites and social media channels that the company uses may be updated on Corning's media and website from time to time. Corning encourages investors, media, and other interested parties to review the information Corning may publish through its website and social media channels as described above, in addition to the company's SEC filings, press releases, conference calls, and webcasts. About Gerresheimer Gerresheimer is a leading global partner to the pharma and healthcare industries. The company's special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with 10,000 employees and manufacturing operations in the local markets, close to customers. It has over 40 production facilities in Europe, North and South America and Asia generating revenue in excess of EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products. About Corning Incorporated Corning (www.corning.com) is one of the world's leading innovators in materials science. For more than 160 years, Corning has applied its unparalleled expertise in specialty glass, ceramics, and optical physics to develop products that have created new industries and transformed people's lives. Corning succeeds through sustained investment in R&D, a unique combination of material and process innovation, and close collaboration with customers to solve tough technology challenges. Corning's businesses and markets are constantly evolving. Today, Corning's products enable diverse industries such as consumer electronics, telecommunications, transportation, and life sciences. They include damage-resistant cover glass for smartphones and tablets; precision glass for advanced displays; optical fiber, wireless technologies, and connectivity solutions for high-speed communications networks; trusted products that accelerate drug discovery and manufacturing; and emissions-control products for cars, trucks, and off-road vehicles.


This report studies Wine and Tobacco Packaging in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering By types, the market can be split into Glass Bottles Wine Packaging Metal Cans Wine Packaging Paper Packaging Aluminium Foil Packaging Others By Application, the market can be split into Wine Tobacco By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India Global Wine and Tobacco Packaging Market Professional Survey Report 2017 1 Industry Overview of Wine and Tobacco Packaging 1.1 Definition and Specifications of Wine and Tobacco Packaging 1.1.1 Definition of Wine and Tobacco Packaging 1.1.2 Specifications of Wine and Tobacco Packaging 1.2 Classification of Wine and Tobacco Packaging 1.2.1 Glass Bottles Wine Packaging 1.2.2 Metal Cans Wine Packaging 1.2.3 Paper Packaging 1.2.4 Aluminium Foil Packaging 1.2.5 Others 1.3 Applications of Wine and Tobacco Packaging 1.3.1 Wine 1.3.2 Tobacco 1.3.3 Application 3 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 2 Manufacturing Cost Structure Analysis of Wine and Tobacco Packaging 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Wine and Tobacco Packaging 2.3 Manufacturing Process Analysis of Wine and Tobacco Packaging 2.4 Industry Chain Structure of Wine and Tobacco Packaging 8 Major Manufacturers Analysis of Wine and Tobacco Packaging 8.1 Innovia Films 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Product A 8.1.2.2 Product B 8.1.3 Innovia Films 2016 Wine and Tobacco Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Innovia Films 2016 Wine and Tobacco Packaging Business Region Distribution Analysis 8.2 ITC 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Product A 8.2.2.2 Product B 8.2.3 ITC 2016 Wine and Tobacco Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 ITC 2016 Wine and Tobacco Packaging Business Region Distribution Analysis 8.3 International Paper 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Product A 8.3.2.2 Product B 8.3.3 International Paper 2016 Wine and Tobacco Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 International Paper 2016 Wine and Tobacco Packaging Business Region Distribution Analysis 8.4 Philips Morris International 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Product A 8.4.2.2 Product B 8.4.3 Philips Morris International 2016 Wine and Tobacco Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Philips Morris International 2016 Wine and Tobacco Packaging Business Region Distribution Analysis 8.5 Ball 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Product A 8.5.2.2 Product B 8.5.3 Ball 2016 Wine and Tobacco Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Ball 2016 Wine and Tobacco Packaging Business Region Distribution Analysis 8.6 Bemis 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Product A 8.6.2.2 Product B 8.6.3 Bemis 2016 Wine and Tobacco Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Bemis 2016 Wine and Tobacco Packaging Business Region Distribution Analysis 8.7 British American Tobacco 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Product A 8.7.2.2 Product B 8.7.3 British American Tobacco 2016 Wine and Tobacco Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 British American Tobacco 2016 Wine and Tobacco Packaging Business Region Distribution Analysis 8.8 Novelis 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Product A 8.8.2.2 Product B 8.8.3 Novelis 2016 Wine and Tobacco Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Novelis 2016 Wine and Tobacco Packaging Business Region Distribution Analysis 8.9 Reynolds 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.2.1 Product A 8.9.2.2 Product B 8.9.3 Reynolds 2016 Wine and Tobacco Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Reynolds 2016 Wine and Tobacco Packaging Business Region Distribution Analysis 8.10 Siegwerk 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.2.1 Product A 8.10.2.2 Product B 8.10.3 Siegwerk 2016 Wine and Tobacco Packaging Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 Siegwerk 2016 Wine and Tobacco Packaging Business Region Distribution Analysis 8.11 Amcor 8.12 Ardagh 8.13 Gerresheimer 8.14 Owens-Illinois 8.15 Rexam 8.16 Smurfit Kappa 8.17 Acorn Paper 8.18 Bormioli Rocco 8.19 Brick Packaging 8.20 Consol Glass 8.21 Hindusthan National Glass & Industries 8.22 Koa Glass 8.23 Piramal Glass 8.24 Scholle 8.25 Stolzle Glass 8.26 Vetropack Holding 8.27 Victory Paper and Packaging 8.28 Vidrala 8.29 Vitro Packaging 8.30 Wiegand-Glas For more information, please visit https://www.wiseguyreports.com/sample-request/1272403-global-wine-and-tobacco-packaging-market-professional-survey-report-2017


News Article | May 15, 2017
Site: marketersmedia.com

— Factors such as increasing demand for different-sized packs and growing focus on packaging as a significant tool for brand differentiation are favouring the growth of the PET packaging market. Moreover, growth in sectors such as food, beverage, personal care, and pharmaceutical, and rise in demand of sustainable & recyclable packaging is fueling the market. The emerging economies of Asia Pacific and Latin America hold a great potential for the PET packaging market. Volatility in raw material prices is hampering the PET packaging market. Bottles & jars are highly chosen due to recyclability, ease and flexibility. PET packaging is ideal in the food industry because it preserves the freshness of food items and extends the shelf life. Asia-Pacific region is expected to grow at a faster pace owing to less labor costs, tremendous industrialization, a vast scope for FDI, and emerging economic conditions. Some of the key players in the market include Smurfit Kappa Group PLC, Rexam PLC, Resilux NV, Klöckner Pentaplast GmbH & Co. Kg, Huhtamaki Group, GTX Hanex Plastic Sp.Z O.O., Graham Packaging Company, Gerresheimer AG, E. I. Du Pont De Nemours and Company (Dupont), Dunmore, CCL Industries, Inc., Berry Plastics Group Inc. and Amcor Limited. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Stratistics MRC We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. For more information, please visit http://www.strategymrc.com/


Receive press releases from iHealthcareAnalyst, Inc.: By Email Global Disposable Syringes Market Analysis: Products, Growth Trends and Forecast to 2020, New Research by iHealthcareAnalyst, Inc. Disposable Syringes Market by Syringe Types (Safety Syringes – Automatic Syringes and Manual Retractable Syringes, Non-Retractable Syringes; and Conventional Syringes – With or Without Needles) 2016-2020 Maryland Heights, MO, February 17, 2017 --( Browse Disposable Syringes Market by Syringe Types (Safety Syringes – Automatic Syringes and Manual Retractable Syringes, Non-Retractable Syringes; and Conventional Syringes – With or Without Needles) 2016-2020 report at https://www.ihealthcareanalyst.com/report/disposable-syringes-market/ Globally, disposable syringes are more popular than re-usable syringes, primarily due to cost, accuracy, sterility, and ease of handling. Syringes equipped with safety mechanisms are known as safety syringes. Safety syringes protect patients and health care professionals from accidental needlestick injuries. Disposable Syringes with wide market potential are being used for intravenous or intramuscular injections and are fast replacing the age-old glass syringes due to their availability in sterilized condition, ready to use, and cost effectiveness. Disposable syringes are the most sold medical devices in the world. An estimated 39,000 million units are sold annually, with market value of approximately USD 4,935.8 million. The global disposable syringes market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on the syringe type (safety syringes – automatic and manual retractable, non-retractable syringes; and conventional syringes either with or without needles), and forecasts growth trends (CAGR% - 2016 to 2020). The global disposable syringes market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global disposable syringes market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. Major players operating in the global disposable syringes market and included in this report are B. Braun Melsungen AG, Becton, Dickinson & Company, Medtronic plc (Covidien plc), Codan Medizinische Geräte GmbH & Co. KG, Gerresheimer AG, Retractable Technologies, Inc., Smiths Medical, Star Syringe, Terumo Corporation, and Unilife Corporation. To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/disposable-syringes-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, February 17, 2017 --( PR.com )-- The global disposable syringes market to reach nearly USD 7.8 Billion in 2020, at a CAGR of 9.1% from 2016 to 2020, due to growth in injectable drugs and point-of-care administration worldwide.Browse Disposable Syringes Market by Syringe Types (Safety Syringes – Automatic Syringes and Manual Retractable Syringes, Non-Retractable Syringes; and Conventional Syringes – With or Without Needles) 2016-2020 report at https://www.ihealthcareanalyst.com/report/disposable-syringes-market/Globally, disposable syringes are more popular than re-usable syringes, primarily due to cost, accuracy, sterility, and ease of handling. Syringes equipped with safety mechanisms are known as safety syringes. Safety syringes protect patients and health care professionals from accidental needlestick injuries. Disposable Syringes with wide market potential are being used for intravenous or intramuscular injections and are fast replacing the age-old glass syringes due to their availability in sterilized condition, ready to use, and cost effectiveness. Disposable syringes are the most sold medical devices in the world. An estimated 39,000 million units are sold annually, with market value of approximately USD 4,935.8 million.The global disposable syringes market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on the syringe type (safety syringes – automatic and manual retractable, non-retractable syringes; and conventional syringes either with or without needles), and forecasts growth trends (CAGR% - 2016 to 2020). The global disposable syringes market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global disposable syringes market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.Major players operating in the global disposable syringes market and included in this report are B. Braun Melsungen AG, Becton, Dickinson & Company, Medtronic plc (Covidien plc), Codan Medizinische Geräte GmbH & Co. KG, Gerresheimer AG, Retractable Technologies, Inc., Smiths Medical, Star Syringe, Terumo Corporation, and Unilife Corporation.To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/disposable-syringes-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.


The global market for ampoule and syringes demonstrates a highly dynamic and competitive landscape, finds a new research report by Transparency market Research (TMR). The market has been largely dominated by Becton, Dickinson and Co., Gerresheimer AG, West Pharmaceuticals, Schott AG, and Nipro Corp., which collectively, held a share of nearly 77% in the overall market in 2015. Hitherto, these companies have been concentrating on making heavy investments in R&D activities; however, their focus is likely to shift towards constructing manufacturing facilities in high growth regions, such as India and China in the near future. Apart from this. Strategic alliance with leading regional participants will be another key focus area for these players over the next few years, states the research report. As per the research study, the global market for ampoules and syringes, which stood at US$5.1 bn in 2015, is likely to progress at an impressive CAGR of 10.50% during the period from 2016 to 2024, increasing the opportunity in this market to US$12.4 bn by the end of the period of the forecast. The demand for glass ampoules and glass syringes has been much higher than other products in this market and is expected to remain so over the years to come. An exhaustive study of the geographical segmentation of the worldwide ampoule and syringes market has also been included in this research study. According to the report, the worldwide market for ampoule and syringes stretches across Europe, the Middle East, and Africa (EMEA), Asia Pacific (APAC), Countries under the North American Free Trade Agreement (NAFTA), i.e., the U.S., Canada, and Mexico, and the Rest of the World. EMEA has been leading the global market over the last few years and is expected to retain its position throughout the forecast period. The presence of a state-of-art medical and healthcare infrastructure, increasing shift towards home healthcare, and the rising awareness among consumers regarding the benefits of ampoules and prefilled syringes in the region. Europe has emerged as the key contributor to the EMEA market for ampoule and syringes and is anticipated to remain seated in this position in the near future. The NAFTA ampoule and syringes market is also expected to witness healthy growth over the next few years, thanks to the presence of a large number of leading pharmaceutical companies in this region, notes the study. Increasing Trend of Home Healthcare to Influence Demand for Ampoules and Syringes "The substantial rise in the geriatric population suffering from various chronic diseases, together with the lower cost of progression-free survival (PFS) compared to hospitals or ambulatory service centers (ASCs) care, has augmented the trend of home healthcare, which is the main factor behind the growth of the ampoules and syringes market," says an analyst at TMR. As syringes ensure deliver precise dosages, helping patients self-administer the medicine without any formal medical training, their usage in home healthcare and point-of-care administration has increased significantly. In addition to this, with considerable advancements in the biologics and biosimilars market, the demand for ampoules and prefilled syringes is expected to increase remarkably over the forecast period. On the FLIP SIDE, the increasing product recalls due to breakages and leachables and the high cost associated with the temperature-controlled packaging needed for temperature-sensitive drugs may hamper the growth of this market to some extent in the near future, states the report. The study presented here is based on a report by Transparency Market Research (TMR) titled "Ampoules and Syringes Market (Ampoule Product Type - Glass Ampoules (Type I, Type II, and Type III), Plastic Ampoules (PVC, Polyethylene, Polypropylene, PET, EVA, and Polycarbonate), Cyclic Olefin Copolymers, and Cyclic Olefin Polymers; Syringe Product Type - Polymer Syringes (Cyclic Olefin Copolymers, Cyclic Olefin Polymers, and PP) and Glass Syringes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016-2024." The global ampoules and syringes market are segmented as follows Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR's syndicated reports strive to provide clients to serve their overall research requirement.


Pharmaceutical Packaging is the packages used for medicine. It includes glass packaging, plastic packaging, aluminum foil packaging, and other pharmaceutical packaging. And applications of pharmaceuticals packaging are oral drugs, injectable and other areas. For more information or any query mail at sales@wiseguyreports.com This report focuses on the Pharmaceuticals Packaging in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Plastic and Polymers Paper & Paperboard Glass Aluminum Foil Market Segment by Applications, can be divided into Oral Drugs Injectable Others 2 Manufacturers Profiles 2.1 Amcor 2.1.1 Business Overview 2.1.2 Pharmaceuticals Packaging Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Amcor Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 ACG 2.2.1 Business Overview 2.2.2 Pharmaceuticals Packaging Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 ACG Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Gerresheimer 2.3.1 Business Overview 2.3.2 Pharmaceuticals Packaging Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Gerresheimer Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Schott 2.4.1 Business Overview 2.4.2 Pharmaceuticals Packaging Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Schott Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 DuPont? 2.5.1 Business Overview 2.5.2 Pharmaceuticals Packaging Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 DuPont? Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 West-P 2.6.1 Business Overview 2.6.2 Pharmaceuticals Packaging Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 West-P Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Bilcare 2.7.1 Business Overview 2.7.2 Pharmaceuticals Packaging Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Bilcare Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Nipro 2.8.1 Business Overview 2.8.2 Pharmaceuticals Packaging Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Nipro Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 AptarGroup 2.9.1 Business Overview 2.9.2 Pharmaceuticals Packaging Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 AptarGroup Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Svam Packaging 2.10.1 Business Overview 2.10.2 Pharmaceuticals Packaging Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 Svam Packaging Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 Bemis Healthcare 2.11.1 Business Overview 2.11.2 Pharmaceuticals Packaging Type and Applications 2.11.2.1 Type 1 2.11.2.2 Type 2 2.11.3 Bemis Healthcare Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 Datwyler 2.12.1 Business Overview 2.12.2 Pharmaceuticals Packaging Type and Applications 2.12.2.1 Type 1 2.12.2.2 Type 2 2.12.3 Datwyler Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 NGPACK 2.13.1 Business Overview 2.13.2 Pharmaceuticals Packaging Type and Applications 2.13.2.1 Type 1 2.13.2.2 Type 2 2.13.3 NGPACK Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14 Jal Extrusion 2.14.1 Business Overview 2.14.2 Pharmaceuticals Packaging Type and Applications 2.14.2.1 Type 1 2.14.2.2 Type 2 2.14.3 Jal Extrusion Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15 SGD 2.15.1 Business Overview 2.15.2 Pharmaceuticals Packaging Type and Applications 2.15.2.1 Type 1 2.15.2.2 Type 2 2.15.3 SGD Pharmaceuticals Packaging Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Pharmaceuticals Packaging Market Competition, by Manufacturer 3.1 Global Pharmaceuticals Packaging Sales and Market Share by Manufacturer 3.2 Global Pharmaceuticals Packaging Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Pharmaceuticals Packaging Manufacturer Market Share 3.3.2 Top 6 Pharmaceuticals Packaging Manufacturer Market Share 3.4 Market Competition Trend For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


Global Sterile Medical Packaging market is accounted for $26.55 billion in 2015 and is expected to reach $42.85 billion by 2022 growing at a CAGR of 7.07%. Rising Adoption of Sterile packaging in packaging of medical equipment, pharmaceutical and biological products is one of the major factors driving the market. Factors such as rising healthcare awareness and disposable income are further fueling the market. However, maintaining medical packaging integrity is restricting the market growth. Pharmaceuticals and Biologics segment is expected to witness a highest share during the forecast period owing to its applications. North America accounted for the largest share in the market. Moreover, Asia Pacific is expected to witness the highest CAGR during the forecast period. The favourable growth is attributed to rising healthcare awareness and technological advancements. Some of the key players in global sterile medical packaging market include ALARIS Medical Systems, Honeywell International Incorporated, 3M Company, ESCO Technologies Incorporated, Becton, Dickinson and Company, Kimberly-Clark Corporation, Bemis Company Incorporated, Alcan Incorporated, Intercome Packaging Company Limited, Ethox Corporation, Abbott Laboratories, Gerresheimer Glass Inc., Baxter International Incorporated, Alcoa Incorporated, Unicep Packaging, Inc., and Amcor Limited. Products Covered: • Clamshell and Lids • Prefillable Syringes • Bottles • Vials and Ampoules o Pouches & Bags o Liner Tear Bags o Spout Pouches o Gusset Bags o Header Bags o Semi Ultra Clean Bags • IV Containers • Thermoform Trays • Other Products Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements For more information, please visit https://www.wiseguyreports.com/sample-request/674322-sterile-medical-packaging-global-market-outlook-2016-2022


- Proposed dividend of EUR 1.05 per share (2015: EUR 0.85 per share) marks an increase of 23.5% - Revenues up 7.2% in financial year 2016 to EUR 1,375.5m - Adjusted EBITDA climbs to EUR 307.8m; at constant exchange rates to EUR 311.3m - Adjusted earnings per share after non-controlling interests increased from EUR 3.41 to EUR 4.22 - Focus on core business: sale of the Life Science Research Division completed as of October 31, 2016 Gerresheimer AG brought financial year 2016 to a successful close and sees strong growth prospects for the years ahead. Gerresheimer is one of the leading partners to the pharma and healthcare industry worldwide and manufactures glass and plastic pharma and cosmetics packaging. "2016 was a successful year for us. We delivered on our guidance for all key performance indicators and have grown substantially. Moreover, we further sharpened our focus on our core business. Going forward, we will continuously expand our development capabilities and product portfolio for the biotech and specialty pharma industry. In addition, we aim to further increase our profitability. The Company is ready for the challenges in the next years ahead," said Uwe Röhrhoff, CEO of Gerresheimer AG. As of October 31, 2016, Gerresheimer sold its Life Science Research Division-the laboratory glassware business. In accordance with International Financial Reporting Standards (IFRS), the division is therefore classified as a discontinued operation. In simple terms, from the time of classification as a discontinued operation, all income and expense items in the consolidated income statement are adjusted for the current year and retrospectively for all comparative periods to be reported upon and are shown in a separate item. Gerresheimer increased revenues in financial year 2016 (December 1, 2015 to November 30, 2016) by 7.2% to EUR 1,375.5m. On an organic basis, revenues went up by 2.9% to EUR 1,383.1m, within the target range of EUR 1,400m plus or minus EUR 25m. Notable revenue growth was generated with inhalers, plastic pharma packaging, injection vials and cosmetic glass. Adjusted EBITDA climbed in financial year 2016 to EUR 307.8m and at constant exchange rates to EUR 311.3m-at the upper end of the guidance range of EUR 305m plus or minus EUR 10m. The adjusted EBITDA margin was for the first time above the 22% mark, at 22.4% compared with a prior-year figure of 20.5%. Net income increased by 49.3% to EUR 168.2m, notably due to the sale of the Life Science Research Division. Adjusted earnings per share after non-controlling interests rose from EUR 3.41 to EUR 4.22. At 15.8% excluding the Life Science Research Division, average net working capital as a percentage of revenues likewise exceeded the Company's expectations. Net financial debt was scaled back by EUR 89.3m to EUR 788.2m, mainly due to the proceeds from the sale of the Life Science Research Division. Leverage, the ratio of net financial debt to adjusted EBITDA, was reduced from 2.9 to 2.6. Gerresheimer's capital expenditure in financial year 2016, at EUR 113.2m compared with EUR 125.8m in the prior year, corresponded to 8.2% of revenues at constant exchange rates excluding the Life Science Research Division. The Company continued to invest in standardizing and modernizing the machinery park in the glass segment. It also modernized the German cosmetic glass plant in Tettau and further expanded decorating capacity. Expansion continued at the Peachtree City plant in the USA, which produces medical plastic systems such as asthma inhalers. "We are optimistic for the future and continue to invest in key growth markets, even though the beginning of financial year 2016/17 appears to be more difficult than the start of the prior year. Our dividend proposal, representing a 23.5% increase to EUR 1.05 per share, reflects the significant improvement in our financial performance indicators," Uwe Röhrhoff added. Gerresheimer's expectations for financial year 2017 are set out in the following, in each case based on constant exchange rates. For the US dollar-which is expected to have the largest currency impact on the Group currency, accounting for about a third of Group revenues in 2017-Gerresheimer has assumed an exchange rate of approximately USD 1.10 to EUR 1.00. In financial year 2017, Gerresheimer anticipates Group revenues of around EUR 1.43bn (plus or minus EUR 25m) on a constant exchange rate basis, compared with EUR 1,375.5m in 2016. Adjusted EBITDA is expected to increase from EUR 308m in 2016 to some EUR 320m (plus or minus EUR 10m) in financial year 2017. Based on the improvement in adjusted EBITDA, adjusted earnings per share after non-controlling interests-the basis of Gerresheimer AG's dividend policy-is projected to rise to a figure in the range EUR 4.20 per share to EUR 4.55 per share (2016 adjusted for the discontinued operation comprising the Life Science Research Division: EUR 4.07 per share). Largely due to the favorable growth prospects and as a result of the initiatives to boost productivity and quality, capital expenditure in the financial year 2017 is expected to amount to around 8% of revenues at constant exchange rates. The Company's expectations through to the end of 2018 are as follows: At the Annual General Meeting on April 26, 2017, the Management Board and Supervisory Board will be jointly proposing that a dividend of EUR 1.05 per share be paid out for financial year 2016. This represents an increase of 23.5% against the prior-year dividend. The dividend ratio amounts to 24.9% of adjusted net income after non-controlling interests. The Annual Report is available here: http://www.gerresheimer.com/en/investor-relations/reports Corss reference: Full press release including table is available at: http://www.presseportal.de/nr/9072/dokument

Loading Gerresheimer collaborators
Loading Gerresheimer collaborators